NASDAQ:CYTK

Cytokinetics Stock Predictions

etoro logo Buy CYTK
*Your capital is at risk
$70.71
-0.200 (-0.282%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CYTK Prediction Chart

CYTK Predictions History

Latest community submissions for CYTK.
Predictor Target Session Target Price Result Direction Accuracy Score
Feb 23, 2026 $66.93 -1.49% $68.26 X 98.05% 0
Feb 23, 2026 $67.31 -0.93% $68.26 X 98.60% 1
Feb 23, 2026 Bullish $68.26 V 1
Aug 28, 2025 $38.49 +1.73% $37.35 X 96.96% 0
Aug 28, 2025 $37.42 -1.08% $37.35 V 99.81% 6
Aug 28, 2025 Bullish $37.35 X 0
Aug 13, 2025 $34.69 +1.10% $34.31 X 98.90% 1
Aug 13, 2025 Bullish $34.31 X 0
AlexVel AlexVel Pro
May 4, 2022 $38.99 -2.53% $41.03 X 95.03% 0
Cucumba Cucumba Amateur
May 3, 2022 $38.50 -3.58% $40.00 X 96.25% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CYTK with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CYTOKINETICS
Cytokinetics
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in pati...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE